Benefits of Adherence to Psychotropic Medications on Depressive Symptoms and Antiretroviral Medication Adherence Among Men and Women Living with HIV/AIDS
- First Online:
- Cite this article as:
- Cruess, D.G., Kalichman, S.C., Amaral, C. et al. ann. behav. med. (2012) 43: 189. doi:10.1007/s12160-011-9322-9
- 345 Downloads
Psychotropic medications are commonly used for depressive symptoms among people living with HIV/AIDS.
We examined the relationships between adherence to psychotropic medications, depressive symptoms, and antiretroviral adherence.
We assessed depressive symptoms among 324 people living with HIV/AIDS across a 3-month period (70% men; mean age 45 years; 90% African–American). Psychotropic and antiretroviral adherence was assessed using monthly, unannounced telephone pill counts. Multiple-regression and mediation analyses were utilized to examine associations under investigation.
Greater depressive symptoms were associated with lower antiretroviral and psychotropic medication adherence. Greater adherence to psychotropic medications regardless of medication class was positively related to higher antiretroviral adherence. Greater adherence to psychotropic medications also significantly mediated the association between depressive symptoms and antiretroviral adherence.
This study demonstrates the benefits of adherence to psychotropic medications on both depressive symptoms and antiretroviral adherence. Future work examining psychotropic medication adherence on disease outcomes in people living with HIV/AIDS is warranted.